Applied Therapeutics, Inc. (APLT)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 4.5300 |
| Open | 4.6300 |
| Bid | 4.7500 x 200 |
| Ask | 4.7900 x 400 |
| Day's Range | 4.6050 - 4.8600 |
| 52 Week Range | 1.1800 - 9.3900 |
| Volume | |
| Avg. Volume | 1,795,919 |
| Market Cap | 543.792M |
| Beta (5Y Monthly) | 1.81 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Reuters
UPDATE 1-US FDA extends review of Applied Therapeutics' genetic disease drug
The U.S. Food and Drug Administration has extended its review of Applied Therapeutics' experimental drug to treat galactosemia, a rare genetic metabolic disease, the company said on Thursday. There are currently no approved treatments for the disease in the United States, which has about 3,000 Galactosemia patients. The FDA delayed its decision on the drug, govorestat, saying it requires additional time to review supplemental analyses submitted by the company.
- Zacks
Applied Therapeutics (APLT) Surges 124% in a Month: Here's Why
Applied Therapeutics (APLT) surges 124% in a month due to encouraging updates from two separate developmental programs for govorestat to treat different rare neurological indications.
- GuruFocus.com
Applied Therapeutics Inc (APLT) Announces Year-End 2023 Financial Results and Clinical Progress
Company Strengthens Balance Sheet and Advances Rare Disease Pipeline
© 2024 Yahoo. All rights reserved.